South Africa and India, which both manufacture drugs and vaccines, made the proposal at the World Trade Organization (WTO) last year, arguing that intellectual property (IP) rules were hindering the urgent scale-up of vaccine production and provision of medical products to some patients. They have faced opposition from some developed nations, but the backing of the African Union (AU) may give renewed impetus for the push to relax IP rules. John Nkengasong, director of the Africa Centers for Disease Control and Prevention, told a news conference that IP transfer was a “win-win for everybody” that would address the huge inequalities in global public health. Nkengasong added the Africa CDC’s regulatory taskforce had approved two versions of AstraZeneca’s COVID-19 vaccine for emergency use, a day after Ghana received its first AstraZeneca doses from global vaccine distribution facility COVAX. He said the developers of Russia’s Sputnik V vaccine had submitted a “full dossier” of data to the Africa CDC and that in the coming days an expert panel would review the data and make a pronouncement.
SOURCE: REUTERS AFRICA
More Stories
Best Style Moments of Tems
To the World
From ‘The Woman King’ to Netflix’s ‘African Queens’ – How Africa’s History Went Pop
Who is Pretty Yende, the Soprano Performing at King Charles III’s Coronation?
Discover Dakar: From African Art to Rooftop Hangouts and Culinary Gems
Graffiti Now Covers the Walls of Libya’s Ancient City, a UNESCO World Heritage Site
When to Visit Malawi
The Beauty about Exploring Africa is that the Continent has a Lot to Offer
Ugandan Kids get Introduced to Irish Dancing Via Online Lessons
Get a Symmetrical Trim at this Kenyan Barber
Standard Bank Hosts Central Bankers to Demonstrate Africa’s Potential to Learn – and Lead
Ghana’s Debt Crisis is Affecting Companies Beyond its Borders